These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37070985)

  • 61. Thymol Increases Sensitivity of Clinical Col-R Gram-Negative Bacteria to Colistin.
    Yao Z; Feng L; Zhao Y; Zhang X; Chen L; Wang L; Zhang Y; Sun Y; Zhou T; Cao J
    Microbiol Spectr; 2022 Aug; 10(4):e0018422. PubMed ID: 35700133
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
    Yang X; Ammeter D; Idowu T; Domalaon R; Brizuela M; Okunnu O; Bi L; Guerrero YA; Zhanel GG; Kumar A; Schweizer F
    Eur J Med Chem; 2019 Aug; 175():187-200. PubMed ID: 31078866
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multidrug-resistant gram-negative bacterial infections after liver transplantation - spectrum and risk factors.
    Zhong L; Men TY; Li H; Peng ZH; Gu Y; Ding X; Xing TH; Fan JW
    J Infect; 2012 Mar; 64(3):299-310. PubMed ID: 22198738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens.
    Saha S; Savage PB; Bal M
    J Appl Microbiol; 2008 Sep; 105(3):822-8. PubMed ID: 18452533
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cefiderocol: A Siderophore Cephalosporin.
    El-Lababidi RM; Rizk JG
    Ann Pharmacother; 2020 Dec; 54(12):1215-1231. PubMed ID: 32522005
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of antibiotic resistance in the intensive care unit setting.
    Petrosillo N; Capone A; Di Bella S; Taglietti F
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.
    Meng F; Liu Y; Nie T; Tang C; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
    Appl Environ Microbiol; 2022 May; 88(10):e0037122. PubMed ID: 35499329
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymyxin antibiotics for gram-negative infections.
    Arnold TM; Forrest GN; Messmer KJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):819-26. PubMed ID: 17420197
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study.
    Siwakoti S; Subedi A; Sharma A; Baral R; Bhattarai NR; Khanal B
    Antimicrob Resist Infect Control; 2018; 7():114. PubMed ID: 30275945
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants.
    Yu B; Roy Choudhury M; Yang X; Benoit SL; Womack E; Van Mouwerik Lyles K; Acharya A; Kumar A; Yang C; Pavlova A; Zhu M; Yuan Z; Gumbart JC; Boykin DW; Maier RJ; Eichenbaum Z; Wang B
    ACS Infect Dis; 2022 Aug; 8(8):1491-1508. PubMed ID: 35801980
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens.
    Ruiz Ramos J; Salavert Lletí M
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):45-54. PubMed ID: 31131592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characterization of a new aerosol antibiotic/adjuvant combination for the treatment of P. aeruginosa lung infections.
    Douafer H; Andrieu V; Wafo E; Brunel JM
    Int J Pharm; 2020 Aug; 586():119548. PubMed ID: 32565286
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria.
    Cepas V; López Y; Muñoz E; Rolo D; Ardanuy C; Martí S; Xercavins M; Horcajada JP; Bosch J; Soto SM
    Microb Drug Resist; 2019; 25(1):72-79. PubMed ID: 30142035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock.
    Pop-Vicas A; Opal SM
    Virulence; 2014 Jan; 5(1):206-12. PubMed ID: 24200870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management.
    Kaye KS; Pogue JM
    Pharmacotherapy; 2015 Oct; 35(10):949-62. PubMed ID: 26497481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana.
    Agyepong N; Govinden U; Owusu-Ofori A; Essack SY
    Antimicrob Resist Infect Control; 2018; 7():37. PubMed ID: 29541448
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multidrug-resistant Gram-negative infections: what are the treatment options?
    Giamarellou H; Poulakou G
    Drugs; 2009 Oct; 69(14):1879-901. PubMed ID: 19747006
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria.
    Fadli M; Chevalier J; Saad A; Mezrioui NE; Hassani L; Pages JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):325-30. PubMed ID: 21752605
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.